Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 16, Issue 1, Pages 124
Publisher
MDPI AG
Online
2019-01-05
DOI
10.3390/ijerph16010124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
- (2018) Tamer M. Fouad et al. PLoS One
- In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
- (2018) Ivana Zagorac et al. Nature Communications
- The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)
- (2018) Oluwadamilola M. Fayanju et al. ANNALS OF SURGERY
- Inflammatory breast cancer outcomes by breast cancer subtype: a population-based study
- (2018) San-Gang Wu et al. Future Oncology
- Protein Kinase Targets in Breast Cancer
- (2017) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program
- (2017) Juanjuan Li et al. Oncotarget
- Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States
- (2017) Lia Scott et al. International Journal of Environmental Research and Public Health
- Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER–Medicare Database
- (2016) Chun Chieh Lin et al. ANNALS OF SURGICAL ONCOLOGY
- Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC
- (2016) Tithi Biswas et al. Clinical Breast Cancer
- 38. Influence of biologic subtype of inflammatory breast cancer on response to neoadjuvant therapy and cancer outcomes
- (2016) T. Hieken et al. EJSO
- Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer
- (2016) Catherine Loveland-Jones et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A69Inflammatory breast cancer management: a single centre experience
- (2015) F. De Iuliis et al. ANNALS OF ONCOLOGY
- Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
- (2015) Paul Baron et al. ANNALS OF SURGICAL ONCOLOGY
- Lymph node status in inflammatory breast cancer
- (2015) Julie S. Wecsler et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome
- (2015) Jennifer M. Matro et al. Clinical Breast Cancer
- Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
- (2015) Jeon Hor Chen et al. Translational Oncology
- Predicting response and survival in chemotherapy-treated triple-negative breast cancer
- (2014) A Prat et al. BRITISH JOURNAL OF CANCER
- Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database
- (2014) Natasha M. Rueth et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
- (2013) H. Masuda et al. ANNALS OF ONCOLOGY
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
- (2013) A. Schneeweiss et al. ANNALS OF ONCOLOGY
- Initial Response to Chemotherapy, Not Delay in Diagnosis, Predicts Overall Survival in Inflammatory Breast Cancer Cases
- (2012) Heather J. Hoffman et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
- (2011) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
- (2011) J. Li et al. ONCOLOGIST
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome
- (2010) Shaheenah Dawood et al. Breast Journal
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early
- (2010) Shaheenah Dawood et al. CANCER
- Management of Inflammatory Breast Cancer After Neoadjuvant Chemotherapy
- (2010) Soumya Abrous-Anane et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- What Is Inflammatory Breast Cancer? Revisiting the Case Definition
- (2010) Paul H. Levine et al. Cancers
- A comprehensive evaluation of outcomes for inflammatory breast cancer
- (2009) Relin Yang et al. BREAST CANCER RESEARCH AND TREATMENT
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data
- (2009) Serban Dan Costa et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammatory breast cancer: MR imaging findings
- (2009) G. Carbognin et al. Radiologia Medica
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
- (2008) Karl Y. Bilimoria et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started